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Abstract
Background: The contribution of different GluN2 subunits of the N-methyl D-aspartate (NMDA) receptor to the
induction of bidirectional hippocampal synaptic plasticity is a controversial topic. As both supporting and refuting
evidence for the hypothesis of subunit specialization in opposing directions of plasticity has accumulated since it
was first proposed a few years ago, we hypothesize that differences in experimental conditions may have in part
contributed to some of the inconsistent results from these studies. Here we investigate the controversial
hypothesis that long-term depression (LTD) is preferentially induced by GluN2B-containing NMDA receptors in area
CA1 of hippocampal slices.
Results: We find that brain slices from 2-3 week old rats prepared in the sagittal orientation have GluN2B-
independent LTD whereas slices prepared in the coronal orientation have GluN2B-dependent LTD. There was no
difference between the orientations in the fraction of the NMDAR EPSC sensitive to a GluN2B-selective antagonist,
leading us to believe that the intracellular signaling properties of the NMDARs were different in the two
preparations. Coronal slices had greater association of LTD-related intracellular signaling protein RasGRF1 with
GluN2B relative to sagittal slices. Antagonism of muscarinic acetylcholine receptors (mAChRs) in the sagittal slices
returned LTD to a GluN2B-dependent form and increased the association of GluN2B with RasGRF1.
Conclusions: These results suggest a novel form of NMDAR modulation by mAChRs and clarify some
disagreement in the literature.
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Background
Long term potentiation (LTP) and long-term depression
(LTD) of synaptic transmission are the two best-under-
stood mechanisms by which the functional connectivity
of neurons is altered [1,2]. In many brain areas,
including the most-studied CA3:CA1 synapse of the hip-
pocampus, the induction of LTP and LTD depends on
activation of N-methyl D-aspartate receptors
(NMDARs). NMDARs are heterotetrameric ligand
gated, Ca
2+ permeable ion channels comprising two
GluN1 subunits and two GluN2 subunits from type
2A-2D [3]. It remains unclear whether different subunits
o ft h eN M D A Ra r ep r e f e r e n t i a l l yc o u p l e dt oL T Po r
LTD induction, however different GluN2 subunits do
confer different functional properties on the NMDAR.
For example the GluN1/GluN2B subtype has slower
channel deactivation and greater coupling to CaMKII
than the GluN1/GluN2A subtype [4,5]. Based on the
prolonged Ca
2+ flux requirements for LTD induction [6]
and the developmentally decaying profile of artificially
inducible LTD [7] matching the early postnatal predo-
minance of GluN2B expression [8], it was hypothesized
that GluN2B is important for LTD induction. In accor-
dance with this idea, the predominant extrasynaptic
localization of GluN2B [9] matches the requirement for
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L T D[ 1 0 ] .I n d e e d ,L T Di nG l u N 2 B
-/- mouse strains is
lost [11,12]. However, the results of experiments on
LTD in-vitro with the GluN2B-selective antagonists Ro
25-6981 (Ro) [13] and Ifenprodil have been in disagree-
ment, with various groups reporting an enhancement of
L T Da tt h eC A 3 : C A 1s y n a p s e[ 1 4 ] ,n oe f f e c to nL T D
induction [15,16] or a complete block of LTD induction
at the same synapse [17]. Outside CA1 the situation is
even more complex, with reports that GluN2B is essen-
tial for LTD in the perirhinal cortex [10], but also that
both GluN2A and GluN2B are required for LTD in the
amygdala [18] and anterior cingulate cortex [19].
Given the number of different laboratories involved in
these studies, it is very likely that some of the conflicting
d a t am a yh a v ea tl e a s ti np a r tr e s u l t e df r o md i f f e r e n t
experimental conditions employed. To try and resolve
this confusion, we studied the methodologies of two
labs with opposing results from experiments with Ro
and LTD in area CA1 [15,17]. This led us to test the
importance of slice orientation for the GluN2B-depen-
dence of LTD induction. Indeed we found that GluN2B-
dependent LTD was a property of the coronal slice
orientation and GluN2B-independent LTD was a prop-
erty of the sagittal orientation. There was no significant
difference in the GluN2B-containing fraction of the
NMDAR EPSC between the two orientations. However,
a muscarinic acetylcholine receptor (mAChR) antago-
nist, scopolamine, conferred Ro-sensitivity on sagittal
LTD. Furthermore, scopolamine led to an increase in
the association of LTD-related signaling molecule
RasGRF1 with GluN2B in sagittal slices. In the basal
state, coronal slices had higher GluN2B-bound RasGRF1
than sagittal slices. This data clarifies some of the exist-
ing literature on GluN2B in LTD and hints toward an
important mechanism of NMDAR regulation.
Results
Slice orientation determines the involvement of GluN2B
in LTD induction
Faced with an apparent contradiction between the
results of some groups regarding the involvement of
GluN2B in LTD induction, we sought a resolution to
the disagreement and an understanding of the underly-
ing physiological mechanism. In one of the studies that
found no involvement of GluN2B in LTD a sagittal [15]
orientation was used when cutting the slices. In work
that found LTD induction absolutely required GluN2B,
the slices were prepared in a coronal orientation [17].
Thus we tested the importance of preparing the hippo-
campal slice in two different orientations. When we
interleaved experiments preparing the slices in one of
the two orientations and treating the slices with the
GluN2B antagonist Ro 25-6981 (Ro), we found that the
LTD induced by 1Hz low frequency stimulation (LFS) in
the sagittal slices was GluN2B-independent (Figure 1A.
Control, n = 13, 78.8 ± 2.66% baseline. Ro, n = 9, 80.7 ±
2.14% baseline. P = 0.619) consistent with the previous
s t u d y[ 1 4 ] ,w h i l eL T Di nt h ec o r o n a ls l i c e sw a s
GluN2B-dependent (Figure 1B. Control, n = 7, 79.5 ±
3.62% baseline. Ro, n = 5, 100.2 ± 3.10% baseline. P =
0.002) in full agreement with the previous work [16].
LTD in the sagittal slices was completely NMDAR-
dependent as shown by interleaved experiments where
the pan-NMDAR antagonist 50 μM D-AP5 blocked
LTD induction completely (data not shown).
A                          
B
Figure 1 LTD in sagittal and coronal slices has different
GluN2B-dependence. Hippocampal slices (400 μM) prepared in
either sagittal (A) or coronal (B) orientations, both with CA3 attached,
were used for extracellular recordings of field excitatory postsynaptic
potentials (fEPSPs) in area CA1. After a stable baseline recording
period (at least 30 minutes) the GluN2B-selective antagonist Ro 25-
6981 (5 μM, Ro) was applied and stimulation at 0.03 Hz continued for
another 30 minutes until a 1 Hz, 15 minute low frequency stimulation
(LFS) at baseline intensity, also in the presence of Ro. Drug
application was stopped at the end of LFS and the magnitude of LTD
was quantified in the last ten minutes of the hour after LFS. In the
slices of either orientation that were not treated with Ro, LFS induced
LTD. Likewise, in the sagittal slices, Ro did not prevent the induction
of LTD (A) although D-AP5 (50 μM) did (data not shown). However, in
the coronal slices treated with Ro, LFS did not induce LTD (B). Scale
bars represent 10 ms and 0.5 mV.
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Page 2 of 8The simplest explanation for the difference in the
GluN2B requirements of LTD induction in the two slice
orientations would be much reduced synaptic expression
of GluN2B in the sagittal slices, leading to GluN2B-
independent LTD. To our surprise, we found no signifi-
cant difference between the effect of Ro on the NMDAR
EPSC from CA1 pyramidal cells in slices prepared in the
sagittal orientation versus cells from coronal slices
(Figure 2, sagittal, n = 8, 39.9 ± 4.72% baseline, Coronal,
n = 7, 30.4 ± 5.33% baseline, P = 0.202). The induction
of LTD is dependent not only on NMDAR activation
and Ca
2+ influx, but on the activation of a cascade of
intracellular processes leading to the expression of
LTD [20]. Thus we supposed that a change
downstream of NMDAR activation was responsible for
the altered subunit dependency of LTD in the two
slice orientations.
mAChR antagonist scopolamine increases the
involvement of GluN2B in LTD induction
The major cholinergic innervation to area CA1 comes
via the medial septal nucleus and releases acetylcholine
onto both principal cells and interneurons [21]. We pro-
posed that the sagittal slice may retain a greater compo-
nent of innervation than the coronal section [22]. Hence
we tested the hypothesis that antagonism of muscarinic
acetylcholine receptors (mAChRs) in the sagittal slices
would recapitulate the phenotype of the coronal slices.
In sagittal slices, we found that co-application of the
mAChR antagonist scopolamine (20 μM) enabled block
of LTD by the GluN2B antagonist Ro. (Figure 3. Scopo-
lamine, n = 9, 79.5 ± 3.64% baseline. Ro + Scopolamine,
n = 6, 93.0 ± 2.64% baseline. P = 0.018). Scopolamine
alone had no significant effect on either the baseline
fEPSP or the magnitude of LFS-induced LTD.
GluN2B interaction with RasGRF1 is higher in conditions
with GluN2B-dependent LTD
We then asked whether the enhanced involvement of
GluN2B in LTD after scopolamine treatment could be
the result of an increased association with an LTD-
related signaling protein. Synaptic plasticity downstream
signaling can involve MAP kinase activation, most com-
monly p38 MAPK for LTD [23,24]. One pathway to
MAP kinase signaling is the small GTPase Ras, which is
active in the GTP-bound state and inactive after bound
GTP is hydrolyzed to GDP. RasGRF1 is a synaptic Ras-
specific guanine nucleotide exchange factor that cata-
lyses the release of GDP from Ras and subsequent acti-
vation by GTP [25]. RasGRF1 is required for LTD
induction and is a binding partner of the carboxyl-tail of
GluN2B [23,26]. When we immunoprecipitated GluN2B
from a lysate of hippocampal slices that had been sub-
ject to scopolamine or control treatments we found that
the ratio of RasGRF1 to GluN2B in the immunoprecipi-
tate was significantly increased in the scopolamine con-
dition, supporting our hypothesis that increased
association of RasGRF1 with GluN2B is part of the
mechanism by which GluN2B can be included in LTD
signaling (Figure 4A,B, Ratio of normalized RasGRF1 in
precipitate scopolamine/control = 2.04 ± 0.451, P =
0 . 0 4 1 5 ,n=1 2 ) .N oi n c r e a s ei nR a s G R F 1o rG l u N 2 B
was detected in the crude lysate from the scopolamine
slices compared to control slices (Figure 4A, B, Ratio of
normalized RasGRF1 in lysate: scopolamine/control =
1.067 ± 0.0674, P = 0.340, n = 12, Ratio of normalized
GluN2B in lysate: scopolamine/control = 1.11 ± 0.137,
P = 0.441, n = 12).
A
B
Figure 2 The GluN2B-mediated fraction of the NMDAR EPSC is
not significantly different between coronal and sagittal
orientations. A) Whole-cell patch clamp recordings from CA1
pyramidal cells in either sagittal or coronal slices were made and
the NMDAR EPSC was isolated at -40 mV in the presence of
bicuculine (10 μM) and NBQX (5 μM). After a 10 minute stable
baseline recording period at stimulation frequency 0.03 Hz, the
GluN2B-selective antagonist Ro was applied for 40 minutes while
stimulation continued. Scale bars represent 200 ms and 200 pA. B)
The level of depression in the NMDAR EPSC induced by Ro, when
quantified in the 40-50 minute epoch, was similar in sagittal and
coronal slices. This indicates activation of a similar number of
synaptic GluN2B-containing NMDARs during baseline synaptic
stimulation in either slice orientation.
Bartlett et al. Molecular Brain 2011, 4:41
http://www.molecularbrain.com/content/4/1/41
Page 3 of 8When we used recovered but untreated coronal or
sagittal hippocampal slices to prepare protein lysates for
the GluN2B coimmunoprecipitation we found that the
immunoprecipitates from the coronal slices were signifi-
cantly enriched for GluN2B-bound RasGRF1 relative to
the sagittal slices (Figure 4C and 4D, coronal/sagittal
ratio of normalized RasGRF1 in GluN2B immunopreci-
pitate = 1.330 ± 0.105, P = 0.020, n = 4). Furthermore,
we also saw a greater level of GluN2B in the coronal
slice lysates relative to slices prepared in the sagittal
orientation but no difference in lysate RasGRF1 (Figure
4C and 4D, Ratio of normalized RasGRF1 in lysate:
coronal/sagittal = 0.909 ± 0.0445, P = 0.086, n = 4,
Ratio of lysate GluN2B coronal/sagittal = 1.60 ± 0.229,
P = 0.04, n = 4). Previously we did not detect a change
in GluN2B at the synapses of coronal versus sagittal
slices using electrophysiology to measure NMDAR
EPSCs (Figure 2).
Discussion
The major findings of this paper are that the GluN2B
subunit involvement in LTD induction in hippocampal
area CA1 is different according to slice orientation and
mAChR activation. The GluN2B-dependence of LTD in
the two orientations is not a consequence of the synap-
tic number of GluN2B-containing receptors, but consis-
tent with an alteration in GluN2B coupling to
downstream signaling molecule RasGRF1 via a mechan-
ism regulated by tonic mAchR activation. We show that
decreased mAchR tone increases the interaction of
GluN2B with RasGRF1 and the involvement of GluN2B
in LTD.
The hippocampus receives cholinergic input from the
medial septum which passes into all subfields including
CA1 [21,27,28]. Alternate orientations of slice have been
shown to change the properties of other synapses in the
brain, for example, the synaptic transmission and plasti-
city of the amygdala is different between coronal and
horizontal slices [29]. It is possible that more cholinergic
fiber tracts are spared in the sagittal orientation than in
the coronal orientation, thus changing the properties of
LTD according to the level of basal mAChR activation.
All of the mAChR subtypes (M1-M5) are present in
CA1 and may contribute to the phenomenon we
observe here [30,31]. M2/4 subtypes couple through Gi
to a reduction in cAMP levels, whereas M1/M3 couple
through Gq to a rise in intracellular Ca
2+ from intracel-
lular stores. mAChRs elevate the excitability of CA1 pyr-
amidal cells and modulate synaptic transmission in
multiple ways from both a presynaptic and postsynaptic
locus.
Presynaptic M2 AChRs inhibit ACh release. Scopola-
mine could thus facilitate ACh release if these receptors
are tonically active [32], but would also inhibit postsy-
naptic receptors. Repetitive stimulation of the Stratum
Orients (SO) has been shown to evoke a cholinergic
slow EPSP that increases CA1 pyramidal cell excitability
[33]. Stratum Radiatum (SR) stimulation preceded by
repetitive SO stimulation delivers enhanced LTP relative
to SR stimulation alone, via facilitation of NMDARs
after inhibition of SK channels [34,35]. The effect of
evoking extra ACh release on the subunit-dependency
of LTD is unknown; however mAChRs also regulate the
surface expression of NMDARs. M1 receptors activate a
pathway involving intracellular Ca
2+, hippocalcin and
clathrin-dependent endocytosis of NMDARs [36]. It
A
B
Figure 3 GluN2B-dependence of LTD is created in the sagittal
slice by a muscarinic acetylcholine receptor antagonist.A )
Sagittal slices were again used for extracellular recordings of
synaptic activity. After a stable baseline stimulation period (0.03 Hz,
>30 minutes), the muscarinic receptor antagonist scopolamine
(Scop, 20 μM) was added to the aCSF with or without GluN2B-
selective antagonist Ro (5 μM) and stimulation continued at
baseline frequency for another 30 minutes. LFS was then begun
while drug application continued. Drug washout began at the
termination of LFS and the magnitude of LTD was quantified in the
final 10 minutes of the hour after LFS. B) In the sagittal slices,
application of scopolamine did not change the induction of LTD or
the baseline fEPSP. However, when co-applied with GluN2B
antagonist Ro there was a significant inhibition of LTD compared to
the slices treated with scopolamine alone. Scale bars represent 10
ms and 0.5 mV.
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Page 4 of 8remains to be seen whether this pathway preferentially
modulates GluN2A or GluN2B.
GluN2B-containing receptors have a predominantly
extrasynaptic localization that may only be accessed by
glutamate during extended stimulation protocols such
as the LFS used here to induce LTD. As such, our quan-
tification of GluN2B via the NMDAR EPSC (Figure 2)
m a yo v e r l o o kd i f f e r e n c e si nt h ee x t r a s y n a p t i cN M D A R
population between the slice orientations. Indeed, we
observed greater GluN2B levels in the lysates of coronal
slices relative to sagittal slices (Figure 4). Therefore, cor-
onal slices may have greater involvement of GluN2B in
LTD because of greater GluN2B levels relative to sagittal
s l i c e s ,a sw e l la sg r e a t e ri n t e r a c t i o no ft h e s eN M D A R
subunits with RasGRF1 in the coronal slices (Figure 4).
Diffuse, rather than synaptic, transmission by acetyl-
choline is suggested by the lack of co-localization of
cholinergic varicosities with glutamatergic synaptic ele-
ments and the tonic baseline concentration of ACh in
the extracellular space of slices [37]. Tonic extracellular
ACh levels in the slice would explain the action of sco-
polamine, and may be determined by slice preparation
conditions. Higher extracellular Ach in the sagittal slice
relative to the coronal slice would be consistent with
the current study. Ambient ACh would not be restricted
to the synapse and could modulate mAChRs in the vici-
nity of extrasynaptic GluN2B-containing receptors to
elicit a change in GluN2B downstream signaling.
RasGRF1 is coupled to p38 MAPK activation, required
for LTD induction [23] and associates with the
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Figure 4 Greater association of GluN2B with RasGRF1 occurs under conditions that show GluN2B involvement in LTD. A,B) Sagittal
hippocampal slices were prepared with the same methodology as for the electrophysiological experiments and treated with control aCSF (C) or
20 μM scopolamine in aCSF (S) for 2 hrs, followed by homogenization in RIPA buffer. 500 μg of each lysate was used for immunoprecipitation
with a polyclonal GluN2B antibody bound to protein A sepharose. After washing in RIPA, the coIPs were subjected to SDS PAGE and Western
blot, alongside 30 μg per lane of the crude lysates. The blots were sequentially probed with RasGRF1 and GluN2B antibodies using HRP- and AP-
conjugated secondary antibodies respectively. In each coimmunoprecipitate the level of RasGRF1 was normalized to GluN2B and then a
scopolamine/control ratio was calculated and averaged across experiments. C, D) Coronal (C) or sagittal (S) slices were prepared and recovered
in the absence of scopolamine. The lysates were processed and taken forward into immunoprecipitation as described above.
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Page 5 of 8C-terminal domain of GluN2B [26]. The increased asso-
ciation of GluN2B and RasGRF1 seen in this study after
scopolamine treatment of slices suggests a mechanism
by which mAChR activation usually restricts the invol-
vement of GluN2B in the signaling for LTD. When
tonic activation of mAChRs is prevented in the sagittal
slice by mAChR antagonism there is greater involve-
ment of GluN2B in LTD induction (Figure 3). In the
untreated condition there is greater association of
GluN2B with RasGRF1 in the coronal slices relative to
the sagittal slices (Figure 4), suggesting a mechanism to
account for the sensitivity of coronal LTD to the
GluN2B-selective antagonist Ro 25-6981.
Loss of cholinergic brain function is a factor in normal
aging and is especially prominent in several neurodegen-
erative disorders [38,39]. Our data suggests that reduc-
tion in acetylcholine occupation of muscarinic receptors
leads to increased LTD-related- and RasGRF1/Ras/
MAPK signaling from GluN2B-containing NMDA
receptors. Considering that GluN2B-containing, extrasy-
naptic NMDA receptors promote excitotoxic cell death
while synaptic GluN2A-containing receptors promote
cell survival [40-45], it is tempting to speculate that this
mechanism is important in glutamate-receptor related
pathology.
Conclusions
We conclude that the difference between some labs
doing experiments on GluN2B involvement in LTD
[15-17] can be explained at least in part by slice orienta-
tion. This highlights the need for more physiologically
relevant preparations such as behaving animals [46].
Furthermore, we have found that there is flexibility in
the coupling of GluN2B to LTD induction, such that
reduced signaling from mAChRs increases the associa-
tion of GluN2B with RasGRF1 and the sensitivity of
LTD to a GluN2B antagonist. Thus, the NMDAR subu-
nit rules in regulating synaptic plasticity may be more
dynamic then previously envisaged, and subject to
dynamic regulation under different physiological and
pathological conditions.
Methods
Slice preparation
Male Sprague-Dawley rats aged 14-21 days were eutha-
nized in accordance with UBC animal care policy and
the brain rapidly removed into ice-cold (2-4°C) ‘slicing
aCSF’ comprising (in mM) NaCl 124, KCl 3, NaH2PO4
1.25, NaHCO3 26, Glucose 15, CaCl2 1, MgSO4 10, 310
mOsm and pH 7.35 when gassed with 95% O2 5% CO2.
For sagittal slices, the brain was trimmed to give flat lat-
eral surfaces and then hemisected along the sagittal
plane before being glued onto a vibratome stage with
the medial surface uppermost. For coronal slices the
rostral end of the brain was chopped with a coronal cut
to create a flat surface upon which to glue the brain
with the caudal end uppermost. Slices (400 μMt h i c k )
were prepared from the dorsal hippocampus and recov-
ered at room temperature (23-25°C) for at least 2 hours
in ‘recording’ aCSF with CaCl2 2 mM, MgSO4 1 mM.
Patch-clamp electrophysiology
Slices were superfused with room temperature (23-25°C)
‘recording’ aCSF flowing at 2.5 ml/minute with compo-
sition as above, except including bicuculine methobro-
mide (10 μM) and NBQX (5 μM). Pyramidal neurons in
area CA1 were patched under visual guidance with glass
micropipettes of resistance 4-6 MΩ when filled with a
solution containing (in mM) CsMeSO4 130, NaCl 8,
EGTA 0.5, HEPES 10, QX-314 bromide 5, Mg.ATP 8,
Na.GTP 4, pH 7.25, 295 mOsm. Data acquisition hard-
ware was via Axon Instruments amplifier Multiclamp
700A and analog-digital converter Digidata 1322a. Data
acquisition and analysis software was WinLTP, [47-49].
Cells were voltage clamped at -40 mV and the Schaffer
collateral/commissural pathway was stimulated with a
twisted NiCr bipolar electrode at 0.03 Hz to evoke
NMDAR-mediated EPSCs. After a stable baseline for 20
minutes, the application of Ro 25-6981 began. The mag-
nitude of Ro-induced depression of the NMDA EPSC
was quantified as the average of the 30-40 minute per-
iod after beginning application of Ro. Statistical compar-
ison between the orientations were by t-test.
Extracellular electrophysiology
Slices were superfused with room temperature (23-25°C
) ‘recording’ aCSF at 2.5 ml/minute and field excitatory
postsynaptic potentials (fEPSPs) were measured in stra-
tum radiatum of CA1 using a glass micropipette of
resistance 2 MΩ when filled with aCSF and data acqui-
sition hardware/software as described above. The Schaf-
fer Collateral/Commissural pathway was stimulated as
above to evoke baseline fEPSPs at 50% of the slope at
which population spikes were first visible. Baseline
fEPSPs were recorded for at least 30 minutes and slices
with an unstable baseline were discarded. LTD was
induced by low frequency stimulation (LFS) of 900
pulses at 1Hz, baseline intensity. The magnitude of LTD
was quantified as the average slope of the fEPSP in the
last ten minutes of the hour after LFS. Ro 25-6981 and
scopolamine were from Tocris and both dissolved in
water and then aCSF just before the experiment. Drugs
w e r ea p p l i e da tt i m e si n d i c a t e di nt h ef i g u r e sb yt h e
filled bars. Statistical comparisons were by t-test.
Co-immunoprecipitation
Sagittal or coronal slices were prepared as above and left
to recover at room temperature (23-25°C ) for at least 2
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Page 6 of 8hours. Slices were split into coronal, sagittal, control
(sagittal) and scopolamine (sagittal) groups and the lat-
ter treated with 20 μM scopolamine for 2 hrs. Slices
were homogenized in ice-cold RIPA buffer comprised of
(in mM unless indicated) NaCl 150, Sodium deoxycho-
late 0.3%, Tris 50, EDTA 1, Triton X-100 1%, SDS 0.1%,
protease inhibitor cocktail (Roche), pH 7.4. All following
steps were conducted at 4°C or on ice. The homogenate
was triturated and cleared by centrifugation at 14,000
rpm for 30 minutes. The soluble fraction was quantified
and 500 μg of protein was loaded onto protein A beads
(GE) that had been incubated for 1 hr with rabbit poly-
clonal anti-GluN2B C-terminal (YTW lab) or with nor-
mal rabbit IgG (SantaCruz, #sc2027). Beads were
incubated in protein lysate with rotation overnight
before four 5 minute washes in RIPA buffer and resus-
pension in PBS and sample buffer.
SDS PAGE and Western Blot
Half of each immunoprecipitation was loaded per lane
of an SDS PAGE gel, alongside 30 μg per lane of crude
lysate. Gels were blotted onto PVDF and probed with
mouse monoclonal anti-GluN2B C-terminal (Millipore,
#ab28373) or rabbit polyclonal anti-RasGRF1 (Santa-
Cruz, #sc224). Secondary antibodies were HRP-conju-
gated anti-rabbit (Perkin Elmer, NEF812001), or AP-
conjugated anti-mouse (Promega #S372B). Luminescent
substrates were Pierce ECL substrate for HRP (#32106)
or Thermo Scientific Lumi Phos WB for AP (#34150).
Signals were quantified with Quantity One software
(BioRad) and the level of RasGRF1 in each immunopre-
cipitation was normalized to the respective level of
GluN2B. The ratio of scopolamine to control, or of cor-
onal to sagittal in each experiment (n) was calculated,
then averaged across the experiments and analyzed in a
one sample t-test.
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